Obligation Generali Assicurazioni 10.125% ( XS0802638642 ) en EUR

Société émettrice Generali Assicurazioni
Prix sur le marché 100 %  ▲ 
Pays  Italie
Code ISIN  XS0802638642 ( en EUR )
Coupon 10.125% par an ( paiement annuel )
Echéance 09/07/2042 - Obligation échue



Prospectus brochure de l'obligation Assicurazioni Generali XS0802638642 en EUR 10.125%, échue


Montant Minimal 100 000 EUR
Montant de l'émission 750 000 000 EUR
Description détaillée Assicurazioni Generali est une société d'assurance italienne multinationale, l'une des plus grandes compagnies d'assurance au monde, offrant une gamme diversifiée de produits et services d'assurance et de gestion d'actifs.

L'obligation de type 'corporate bond' identifiée par le code ISIN XS0802638642, émise par Assicurazioni Generali, un acteur majeur et historique du secteur de l'assurance basé en Italie, a récemment atteint sa maturité fixée au 9 juillet 2042 et a été intégralement remboursée à 100% de son pair, confirmant la bonne exécution des engagements de l'émetteur envers ses détenteurs. Cette émission, d'une taille totale de 750 000 000 EUR et libellée en Euro, offrait un taux d'intérêt annuel notable de 10,125% avec une fréquence de paiement du coupon annuelle et était accessible avec une taille minimale d'achat de 100 000 EUR.








Base Prospectus dated 25 May 2021





ASSICURAZIONI GENERALI S.p.A.
(incorporated with limited liability under the laws of the Republic of Italy)
15,000,000,000
Euro Medium Term Note Programme

Assicurazioni Generali S.p.A. ("Assicurazioni Generali" or the "Issuer") has established a Euro Medium Term Note
Programme (the "Programme") for the issuance of 15,000,000,000 in aggregate principal amount of notes (the "Notes").
Under the Programme as described in this Base Prospectus, Assicurazioni Generali may from time to time issue Notes in bearer
form denominated in any currency, as described in further detail herein. Notes issued under the Programme will not have
denominations of less than 100,000 (or, if the Notes are denominated in a currency other than euro, the equivalent amount in
such currency). Notes to be issued under the Programme may comprise (i) unsubordinated Notes (the "Senior Notes"), (ii) tier 3
notes referred to as "More Senior Dated Subordinated Notes" which are subordinated and with a maturity date as described
herein (the "Tier 3 Notes"), (iii) senior dated subordinated notes which are subordinated and with a maturity date as described
herein (the "Senior Dated Subordinated Notes") and (iv) deeply subordinated notes which are deeply subordinated and with,
or without, a maturity date as described herein (the "Deeply Subordinated Notes" and together with the Senior Dated
Subordinated Notes, the "Tier 2 Notes" and, together with the Tier 3 Notes, the "Subordinated Notes").
Notice of the aggregate nominal amount of any tranche of Notes, the interest (if any) payable, the issue price and any other
information relating to the Notes which is not known at the date of this base prospectus (the "Base Prospectus") and which can
only be determined at the time of an individual issue of a Tranche of Notes will be set out in the relevant Final Terms (as
defined below) or, as the case may be, the Drawdown Prospectus.
Application has been made to the Commission de Surveillance du Secteur Financier (the "CSSF") in its capacity as competent
authority in Luxembourg to approve this document as a base prospectus under the Luxembourg Law of 16 July 2019 on
Prospectuses for Securities (the "Luxembourg Prospectus Law"). The CSSF assumes no responsibility for the economic and
financial soundness of the transactions contemplated by this Base Prospectus or the quality or solvency of the Issuer in
accordance with Article 6(4) of the Luxembourg Prospectus Law and only approves this Base Prospectus as meeting the
standards of completeness, comprensibility and consistency imposed by Regulation (EU) 2017/1129 (the "Prospectus
Regulation"). Application has been made to the Luxembourg Stock Exchange for Notes issued under this Base Prospectus to be
admitted to trading on the Regulated Market of the Luxembourg Stock Exchange and for the Notes to be displayed on the
Professional Segment or on the Luxembourg Green Exchange Platform (the "LGX Platform") of the Regulated Market of the
Luxembourg Stock Exchange and to be listed on the Official List of the Luxembourg Stock Exchange during the period of 12
months after the date hereof. The obligation to supplement this Prospectus in the event of significant new factors, material
mistakes or material inaccuracies will not apply following the expiry of that period. The Luxembourg Stock Exchange's
regulated market (the "Regulated Market") is a regulated market for the purposes of the Markets in Financial Investments
Directive, as amended (Directive 2014/65/EC) (as amended, "MiFID II"). The CSSF gives no undertaking as to the economic
or financial opportuneness of the transaction or the quality and solvency of the Issuer in line with the provisions of article 6(4)
of the Luxembourg Prospectus Law.
This Base Prospectus has been approved by the CSSF, as competent authority under the Prospectus Regulation. The CSSF only
approves this Base Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the
Prospectus Regulation. Such approval should not be considered as an endorsement of either the Issuer or the quality of the




Notes that are the subject of this Base Prospectus and investors should make their own assessment as to the suitability of
investing in the Notes.
This Base Prospectus shall be valid for admission to trading of Notes on a regulated market for the purposes of MiFID II for 12
months after the approval by the CSSF, provided that it is completed by any supplement, pursuant to Article 23 of the
Prospectus Regulation, following the occurrence of a significant new factor, a material mistake or a material inaccuracy relating
to the information included (including incorporated by reference) in this Base Prospectus which may affect the assessment of
the Notes. After such date, the Base Prospectus will expire and the obligation to supplement this Base Prospectus in the event of
significant new factors, material mistakes or material inaccuracies will no longer apply.
The Programme also allows for Notes to be unlisted or to be admitted to listing, trading and/or quotation by such other or
further listing authorities, stock exchanges and/or quotation systems as may be agreed with the Issuer (including on the
professional segment (ExtraMOT PRO) of the multi-lateral trading facility (ExtraMOT Market) organised and managed by
Borsa Italiana S.p.A.). Under the Luxembourg Prospectus Law, prospectuses relating to money market instruments having a
maturity at issue of less than 12 months which fall within the definition of securities are not subject to the approval provisions
of Part II of such law, but are subject to the approval provisions of Part III of the Luxembourg Prospectus Law, which requires
the approval of an alleviated prospectus. No money market instruments having a maturity at issue of less than 12 months will
be offered to the public or admitted to trading on a regulated market under this Base Prospectus.
An investment in Notes issued under the Programme involves certain risks. For a discussion of these risks, see "Risk Factors"
on page 19.
Under current legislation in Italy, payments of interest, premium or other income relating to the Notes are subject to substitute
tax (imposta sostitutiva) at a rate of 26 per cent., regardless of maturity. The Issuer will not be liable to pay any additional
amounts to Noteholders in relation to any such substitute tax or withholding. For further information, see "Taxation" on page
318.
Amounts payable under the Notes may be calculated by reference to benchmarks including (i) the Euro-zone interbank offered
rate ("EURIBOR"); (ii) the Singapore interbank offered rate ("SIBOR"); (iii) the Tokyo interbank offered rate ("TIBOR");
(iv) the Hong Kong interbank offered rate ("HIBOR"); (v) the sterling overnight index average rate ("SONIA"); (vi) the
secured overnight financing rate ("SOFR"); (vii) the constant maturity swap rate ("CMS"); and (viii) the Daily Euro Short-term
Rate (the "STR") and amounts payable on Floating Rate Notes and Reset Notes issued under the Programme may, in certain
circumstances, be determined in part by reference to such indices, each as specified in the relevant Final Terms. Each such
index constitutes a benchmark for the purposes of the Benchmark Regulation (Regulation (EU) 2016/1011) (the "EU
Benchmark Regulation"). As at the date of this Base Prospectus, from the above-named list of benchmarks, only the
administrators of EURIBOR, the European Money Markets Institute ("EMMI"), and of SIBOR, ABS Benchmarks
Administration Co Pte Ltd., are included on the register of administrators and benchmarks established and maintained by the the
European Securities and Markets Authority ("ESMA") pursuant to article 36 of the EU Benchmark Regulation. Furthermore, as
far as the Issuer is aware, the administrators of SONIA, SOFR and STR are not required to be registered by virtue of Article 2
of the EU Benchmark Regulation (or of the EU Benchmark Regulation as it forms part of UK domestic law by virtue of the
European Union (Withdrawal Act) 2018 (the "EUWA") (the "UK Benchmark Regulation"), as the case may be). Similarly,
third country benchmarks already used in the European Union (the "EU") prior to 31 December 2023 can still be used in the EU
as a reference for financial instruments, financial contracts, or for measuring the performance of an investment fund before that
date.
A43380138



Arranger
UniCredit
Dealers
Barclays
BBVA
BNP PARIBAS
BofA Securities
Citigroup
Crédit Agricole CIB
Deutsche Bank
Goldman Sachs International
HSBC
J.P. Morgan
Mediobanca
Mizuho Securities
Morgan Stanley
Natixis
Santander Corporate & Investment Banking
Société Générale Corporate & Investment Banking
UniCredit
A43380138



TABLE OF CONTENTS
Page
IMPORTANT NOTICES ................................................................................................................................... 5
GENERAL DESCRIPTION OF THE PROGRAMME ....................................................................................12
RISK FACTORS ...............................................................................................................................................19
INFORMATION INCORPORATED BY REFERENCE ..................................................................................47
CROSS-REFERENCE LIST .............................................................................................................................49
FINAL TERMS AND DRAWDOWN PROSPECTUS .....................................................................................52
FORMS OF THE NOTES .................................................................................................................................53
TERMS AND CONDITIONS OF THE SENIOR NOTES ...............................................................................56
TERMS AND CONDITIONS OF THE TIER 2 NOTES ................................................................................103
TERMS AND CONDITIONS OF THE TIER 3 NOTES ................................................................................167
FORM OF FINAL TERMS OF THE SENIOR NOTES .................................................................................226
FORM OF FINAL TERMS OF THE TIER 2 NOTES ...................................................................................246
FORM OF FINAL TERMS OF THE TIER 3 NOTES ...................................................................................268
OVERVIEW OF PROVISIONS RELATING TO THE NOTES WHILE IN GLOBAL FORM ....................289
USE OF PROCEEDS ......................................................................................................................................293
DESCRIPTION OF THE ISSUER .................................................................................................................295
OVERVIEW FINANCIAL INFORMATION OF THE ISSUER ....................................................................315
TAXATION .....................................................................................................................................................318
SUBSCRIPTION AND SALE ........................................................................................................................330
GENERAL INFORMATION ..........................................................................................................................337

A43380138
4



IMPORTANT NOTICES
This Base Prospectus comprises a base prospectus for the purposes of Article 8 of the Prospectus Regulation.
The Issuer accepts responsibility for the information contained in this document and for the relevant Final
Terms for each Tranche of Notes issued under the Programme and to the best of the knowledge of the Issuer,
the information contained in this document and in the relevant Final Terms for each Tranche of Notes issued
under the Programme is in accordance with the facts and this Base Prospectus makes no omission likely to
affect the import of such information.
This Base Prospectus should be read and construed together with any supplements hereto and with any other
documents incorporated by reference herein and, in relation to any Tranche (as defined herein) of Notes,
should be read and construed together with the relevant Final Terms.
The Issuer has confirmed to the Dealers named under "Subscription and Sale" below that this Base
Prospectus (including for this purpose, each relevant Final Terms) contains all information which according to
the particular nature of the Issuer and the securities offered to the public or admitted to trading on a regulated
market, is necessary to enable investors to make an informed assessment of the assets and liabilities, financial
position, profits and losses, and the prospects of the Issuer and of any rights attaching to such securities and is
(in the context of the Programme and the issue, offering and sale of the Notes) material; that such information
is true and accurate in all material respects and is not misleading in any material respect; that any opinions,
predictions or intentions expressed herein are honestly held or made and are not misleading in any material
respect; that this Base Prospectus does not omit to state any material fact necessary to make such information,
opinions, predictions or intentions (in the context of the Programme and the issue, offering and sale of the
Notes, where applicable) not misleading in any material respect; and that all proper enquiries have been made
to verify the foregoing.
No person has been authorised to give any information or to make any representation not contained in or not
consistent with this Base Prospectus or any other document entered into in relation to the Programme or any
information supplied by the Issuer or such other information as is in the public domain and, if given or made,
such information or representation should not be relied upon as having been authorised by the Issuer or any
Dealer.
No representation or warranty is made or implied by the Dealers or any of their respective affiliates, and
neither the Dealers nor any of their respective affiliates makes any representation or warranty or accepts any
responsibility as to the accuracy or completeness of the information contained in this Base Prospectus.
Neither the delivery of this Base Prospectus or any Final Terms nor the offering, sale or delivery of any Note
shall, in any circumstances, create any implication that the information contained in this Base Prospectus is
true subsequent to the date hereof or the date upon which this Base Prospectus has been most recently
supplemented or that there has been no adverse change, or any event reasonably likely to involve any adverse
change, in the condition (financial or otherwise) of the Issuer since the date hereof or, if later, the date upon
which this Base Prospectus has been most recently supplemented or that any other information supplied in
connection with the Programme is correct at any time subsequent to the date on which it is supplied or, if
different, the date indicated in the document containing the same.
This Base Prospectus may only be used for the purposes for which it has been published. The distribution of
this Base Prospectus and any Final Terms and the offering, sale and delivery of the Notes in certain
jurisdictions may be restricted by law. Persons into whose possession this Base Prospectus or any Final Terms
comes are required by the Issuer and the Dealers to inform themselves about and to observe any such
restrictions. For a description of certain restrictions on offers, sales and deliveries of Notes and on the
distribution of this Base Prospectus or any Final Terms and other offering material relating to the Notes, see
A43380138
5



"Subscription and Sale". In particular, Notes have not been and will not be registered under the United States
Securities Act of 1933 (as amended) (the "Securities Act") and are subject to U.S. tax law requirements.
Subject to certain exceptions, Notes may not be offered, sold or delivered within the United States or to U.S.
persons.
PRIIPs / IMPORTANT ­ EEA RETAIL INVESTORS - If the Final Terms in respect of any Notes includes
a legend entitled "Prohibition of Sales to EEA Retail Investors", the Notes are not intended to be offered, sold
or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the European Economic Area ("EEA"). For these purposes, a retail investor means a person who is
one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of MiFID II; or (ii) a customer
within the meaning of Directive (EU) 2016/97 (as amended, the "Insurance Distribution Directive"), where
that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II.
Consequently, no key information document required by Regulation (EU) No 1286/2014 (the "PRIIPs
Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the
EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any
retail investor in the EEA may be unlawful under the PRIIPS Regulation.
PRIIPs / IMPORTANT ­ UK RETAIL INVESTORS - If the Final Terms in respect of any Notes includes
a legend entitled "Prohibition of Sales to UK Retail Investors", the Notes are not intended to be offered, sold
or otherwise made available to and should not be offered, sold or otherwise made available to any retail
investor in the United Kingdom ("UK"). For these purposes, a retail investor means a person who is one (or
more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms
part of UK domestic law by virtue of the EUWA; or (ii) a customer within the meaning of the provisions of
the Financial Services and Markets Act 2000 (the "FSMA") and any rules or regulations made under the
FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a
professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of
UK domestic law by virtue of the EUWA. Consequently no key information document required by Regulation
(EU) No 1286/2014 as it forms part of UK domestic law by virtue of the EUWA (the "UK PRIIPs
Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the
UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any
retail investor in the UK may be unlawful under the UK PRIIPs Regulation.
MIFID II PRODUCT GOVERNANCE / TARGET MARKET ­ The Final Terms in respect of any Notes
will include a legend entitled "MiFID II Product Governance" which will outline the target market
assessment in respect of the Notes and which channels for distribution of the Notes are appropriate. Any
person subsequently offering, selling or recommending the Notes (a "distributor") should take into
consideration the target market assessment; however, a distributor subject to MiFID II is responsible for
undertaking its own target market assessment in respect of the Notes (by either adopting or refining the target
market assessment) and determining appropriate distribution channels. A determination will be made in
relation to each issue about whether, for the purpose of the MiFID Product Governance rules under EU
Delegated Directive 2017/593 (the "MiFID Product Governance Rules"), any Dealer subscribing for any
Notes is a manufacturer in respect of such Notes, but otherwise neither the Arranger nor the Dealers nor any
of their respective affiliates will be a manufacturer for the purpose of the MIFID Product Governance Rules.
UK MiFIR PRODUCT GOVERNANCE / TARGET MARKET - The Final Terms in respect of any Notes
will include a legend entitled "UK MiFIR product governance" which will outline the target market
assessment in respect of the Notes and which channels for distribution of the Notes are appropriate. Any
person subsequently offering, selling or recommending the Notes (a "distributor") should take into
consideration the target market assessment; however, a distributor subject to the FCA Handbook Product
Intervention and Product Governance Sourcebook (the "UK MiFIR Product Governance Rules") is
A43380138
6



responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or
refining the target market assessment) and determining appropriate distribution channels. A determination will
be made in relation to each issue about whether, for the purpose of the UK MiFIR Product Governance Rules,
any Dealer subscribing for any Notes is a manufacturer in respect of such Notes, but otherwise neither the
Arranger nor the Dealers nor any of their respective affiliates will be a manufacturer for the purpose of the
UK MiFIR Product Governance Rules.
SALES TO CANADIAN INVESTORS - The Notes may be sold only to purchasers purchasing, or deemed
to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106
Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as
defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant
Obligations. Any resale of the Notes must be made in accordance with an exemption from, or in a transaction
not subject to, the prospectus requirements of applicable securities laws.
Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for
rescission or damages if this Base Prospectus (including any amendment thereto) contains a
misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within
the time limit prescribed by the securities legislation of the purchaser's province or territory. The purchaser
should refer to any applicable provisions of the securities legislation of the purchaser's province or territory
for particulars of these rights or consult with a legal advisor.
If applicable, pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of
a non-Canadian jurisdiction, section 3A.4) of National Instrument 33-105 Underwriting Conflicts (NI 33-
105), the Dealers are not required to comply with the disclosure requirements of NI 33-105 regarding
underwriter conflicts of interest in connection with the offering of the Notes.
Neither this Base Prospectus nor any Final Terms constitutes an offer or an invitation to subscribe for or
purchase any Notes and should not be considered as a recommendation by the Issuer, the Dealers or any of
them that any recipient of this Base Prospectus or any Final Terms should subscribe for or purchase any
Notes. Each recipient of this Base Prospectus or any Final Terms shall be taken to have made its own
investigation and appraisal of the condition (financial or otherwise) of the Issuer.
Neither the Issuer, the Arranger nor any of the Dealers makes any representation as to the suitability of any
Green Bonds, Social Bonds or Sustainability Bonds (each as defined herein) to fulfil any green, social or
sustainability criteria required by any prospective investors. If any Green Bonds, Social Bonds or
Sustainability Bonds will be admitted to listing (including the listing or admission to trading thereof on any
dedicated `green', `social', `sustainable' or other equivalently-labelled segment of any stock exchange or
securities market), no representation or assurance is given by the Issuer, the Arranger or any of the Dealers
that such listing or admission satisfies any present or future investor expectations or requirements as regards
any investment criteria or guidelines with which such investor or its investments are required to comply. The
Arranger and the Dealers have not undertaken, nor are they responsible for, any assessment of the eligibility
criteria for Eligible Green Projects, Eligible Social Projects or Eligible Sustainability Projects (each as
defined herein), any verification of whether such projects meet such criteria or the monitoring of the use of
proceeds of any Green Bonds, Social Bonds or Sustainability Bonds (or amounts equal thereto). Investors
should refer to the Issuer's Green Bond Framework, the Issuer's Social Bond Framework and the Issuer's
Sustainability Bond Framework (each as defined herein) which the Issuer may publish from time to time, any
second party opinion delivered in respect thereof, and any public reporting by or on behalf of the Issuer in
respect of the application of the proceeds of any issue of Green Bonds, Social Bonds or Sustainability Bonds
for further information. Any such green, social or sustainability framework and/or second party opinion
and/or public reporting ­ which will be made available in the "investor relations" section of the Issuer's
A43380138
7



website ­ will not be incorporated by reference in this Base Prospectus and neither the Arranger nor any of
the Dealers makes any representation as to the suitability or contents thereof.
The maximum aggregate principal amount of Notes outstanding at any one time under the Programme will
not exceed 15,000,000,000 and, for this purpose, any Notes denominated in another currency shall be
translated into euro at the date of the agreement to issue such Notes, calculated in accordance with the
provisions of the Dealer Agreement (as defined under "Subscription and Sale"). The maximum aggregate
principal amount of Notes which may be outstanding at any one time under the Programme may be increased
from time to time, subject to compliance with the relevant provisions of the Dealer Agreement.
Notes issued pursuant to the Programme may also be rated or unrated. Where an issue of Notes is rated, its
rating will be specified in the relevant Final Terms. A rating is not a recommendation to buy, sell or hold
securities and may be subject to suspension, reduction or withdrawal at any time by the assigning rating
agency. Whether or not each credit rating applied for in relation to the relevant Series of Notes will be issued
by a credit rating agency established in the European Economic Area and registered under Regulation (EC)
No 1060/2009 (the "EU CRA Regulation") or established in the United Kingdom and registered under
Regulation (EC) No 1060/2009 as it forms part of UK domestic law by virtue of the EUWA (the "UK CRA
Regulation" and, together with the EU CRA Regulation, the relevant "CRA Regulation") will be disclosed
in the relevant Final Terms. In general, European regulated investors are restricted under the EU CRA
Regulation and UK regulated investors are restricted under the UK CRA Regulation from using a credit rating
for regulatory purposes unless such rating is issued by a credit rating agency established in the EEA or the
United Kingdom and registered under the relevant CRA Regulation (and such registration has not been
withdrawn or superseded, subject to transitional provisions that apply in certain circumstances). Such general
restriction will also apply in the case of credit ratings issued by non-EEA credit rating agencies or non-UK
credit rating agencies, unless the relevant credit ratings are endorsed by an EEA-registered or UK- registered
credit rating agency or the relevant non-EEA (or non-UK) credit rating agency is certified in accordance with
the relevant CRA Regulation (and such endorsement or certification, as the case may be, has not been
withdrawn or suspended, subject to transitional provisions that apply in certain circumstances).
ESMA is obliged to maintain on its website, https://www.esma.europa.eu/supervision/credit-rating-
agencies/risk a list of credit rating agencies registered and certified in accordance with the EU CRA
Regulation.
In this Base Prospectus, unless otherwise specified, references to "EUR", "euro" or "" are to the single
currency introduced at the start of the third stage of European Economic and Monetary Union and as defined
in Article 2 of Council Regulation (EC) No. 974/98 of 3 May 1998 on the introduction of the euro, as
amended. Unless otherwise specified or where the context requires, references to laws and regulations are to
the laws and regulations of Italy.
This Base Prospectus has been prepared on the basis that, except to the extent sub-paragraph (ii) below may
apply, any offer of Notes in any Member State of the EEA (each, a "Member State") will be made pursuant
to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of
Notes and any offer of Notes in the UK will be made pursuant to an exemption under Regulation (EU)
2017/1129 as it forms part of UK domestic law by virtue of the EUWA (the"UK Prospectus Regulation")
from the requirement to publish a prospectus for offers of Notes. Accordingly any person making or intending
to make an offer in that Member State or the UK of Notes which are the subject of an offering/placement
contemplated in this Base Prospectus as completed by the relevant Final Terms or a Drawdown Prospectus in
relation to the offer of those Notes may only do so (i) in circumstances in which no obligation arises for the
Issuer or any Dealer to publish a prospectus pursuant to Article 3 of the Prospectus Regulation (or the UK
Prospectus Regulation, as the case may be) or supplement a prospectus pursuant to Article 23 of the
A43380138
8



Prospectus Regulation (or the UK Prospectus Regulation, as the case may be), in each case, in relation to such
offer, or (ii) if a prospectus for such offer has been approved by the competent authority in that Member State
or, where appropriate, approved in another Member State and notified to the competent authority in that
Member State (or in the UK, as the case may be) and (in either case) published, all in accordance with the
Prospectus Regulation (or the UK Prospectus Regulation, as the case may be), provided that any such
prospectus has subsequently been completed by the relevant Final Terms or is a Drawdown Prospectus which
specifies that offers may be made other than pursuant to Article 3(2) of the Prospectus Regulation (or the UK
Prospectus Regulation, as the case may be) in that Member State (or in the UK as the case may be), such offer
is made in the period beginning and ending on the dates specified for such purpose in such prospectus or final
terms or drawdown prospectus, as applicable, and the Issuer has consented in writing to its use for the purpose
of such offer. Except to the extent sub-paragraph (ii) above may apply, neither the Issuer nor any Dealer have
authorised, nor do they authorise, the making of any offer of Notes in circumstances in which an obligation
arises for the Issuer or any Dealer to publish or supplement a prospectus for such offer.
The Notes may not be a suitable investment for all investors
Each potential investor in the Notes must determine the suitability of that investment in light of its own
circumstances. In particular, each potential investor should:
(i)
have sufficient knowledge and experience to make a meaningful evaluation of the Notes, the merits
and risks of investing in the Notes and the information contained or incorporated by reference in this
Base Prospectus or any applicable supplement;
(ii)
have access to, and knowledge of, appropriate analytical tools to evaluate, in the context of its
particular financial situation, an investment in the Notes and the impact the Notes will have on its
overall investment portfolio;
(iii)
have sufficient financial resources and liquidity to bear all of the risks of an investment in the Notes,
including Notes with principal or interest payable in one or more currencies, or where the currency
for principal or interest payments is different from the potential investor's currency;
(iv)
understand thoroughly the terms of the Notes and be familiar with the behaviour of any relevant
indices and financial markets; and
(v)
be able to evaluate (either alone or with the help of a financial adviser) possible scenarios for
economic, interest rate and other factors that may affect its investment and its ability to bear the
applicable risks.
Some Notes are complex financial instruments. Sophisticated institutional investors generally do not purchase
complex financial instruments as stand-alone investments. They purchase complex financial instruments as a
way to reduce risk or enhance yield with an understood, measured, appropriate addition of risk to their overall
portfolios. A potential investor should not invest in Notes which are complex financial instruments unless it
has the expertise (either alone or with a financial adviser) to evaluate how the Notes will perform under
changing conditions, the resulting effects on the value of the Notes and the impact this investment will have
on the potential investor's overall investment portfolio.
Furthermore, the conditions of the Notes are governed by English law or, as the case may be, Italian law, in
effect as of the date of this Base Prospectus, as specified in the relevant Final Terms. In the case of
Subordinated Notes governed by English law, the provisions concerning the status of such Subordinated
Notes will be governed by the laws of the Republic of Italy. No assurance can be given as to the impact of any
possible judicial decision or change to applicable law or administrative practice after the date of this Base
Prospectus.
A43380138
9



Neither the Issuer, the Dealers, nor any of their respective affiliates has or assumes responsibility for the
lawfulness of the acquisition of the Notes by a prospective investor in the Notes, whether under the laws of
the jurisdiction of its incorporation or the jurisdiction in which it operates (if different), or for compliance by
that prospective investor with any law, regulation or regulatory policy applicable to it.
The investment activities of certain investors are subject to legal investment laws and regulations, or review
or regulation by certain authorities. Each potential investor should consult its legal advisers to determine
whether and to what extent (i) Notes are legal investments for it, (ii) Notes can be used as collateral for
various types of borrowing and (iii) other restrictions apply to the purchase or pledge of any Notes. Financial
institutions should consult their legal advisors or the appropriate regulators to determine the appropriate
treatment of Notes under any applicable risk-based capital or similar rules.
Singapore SFA Product Classification: In connection with Section 309B of the Securities and Futures Act
(Chapter 289) of Singapore (the "SFA") and the Securities and Futures (Capital Markets Products)
Regulations 2018 of Singapore (the "CMP Regulations 2018"), unless otherwise specified before an offer of
Notes, the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A(1) of
the SFA), that the Notes are `prescribed capital markets products' (as defined in the CMP Regulations
2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of
Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).
Certain figures included in this Base Prospectus have been subject to rounding adjustments; accordingly,
figures shown for the same category presented in different tables may vary slightly and figures shown as totals
in certain tables may not be an arithmetic aggregation of the figures which precede them.
STABILISATION
IN CONNECTION WITH THE ISSUE OF ANY TRANCHE OF NOTES, THE DEALER OR
DEALERS (IF ANY) NAMED AS THE STABILISING MANAGER(S) (THE "STABILISING
MANAGER(S)" (OR ANY PERSON ACTING ON BEHALF OF ANY STABILISING MANAGER(S))
IN THE APPLICABLE SUBSCRIPTION AGREEMENT, MAY OVER-ALLOT NOTES OR EFFECT
TRANSACTIONS WITH A VIEW TO SUPPORTING THE MARKET PRICE OF THE NOTES AT A
LEVEL HIGHER THAN THAT WHICH MIGHT OTHERWISE PREVAIL. HOWEVER
STABILISATION MAY NOT NECESSARILY OCCUR. ANY STABILISATION ACTION MAY
BEGIN ON OR AFTER THE DATE ON WHICH ADEQUATE PUBLIC DISCLOSURE OF THE
TERMS OF THE OFFER OF THE RELEVANT TRANCHE IS MADE AND, IF BEGUN, MAY
CEASE AT ANY TIME, BUT IT MUST END NO LATER THAN THE EARLIER OF 30 DAYS
AFTER THE ISSUE DATE OF THE RELEVANT TRANCHE OF NOTES AND 60 DAYS AFTER
THE DATE OF THE ALLOTMENT OF THE RELEVANT TRANCHE OF NOTES. ANY
STABILISATION ACTION OR OVER-ALLOTMENT MUST BE CONDUCTED BY THE
RELEVANT STABILISING MANAGER(S) (OR ANY PERSON ACTING ON BEHALF OF ANY
STABILISING MANAGER(S)) IN ACCORDANCE WITH ALL APPLICABLE LAWS AND RULES.
MARKET STATISTICS
Information and statistics presented in this Base Prospectus regarding business trends, market trends, market
volumes and the market share of the Issuer or the Generali Group (as defined herein) are either derived from,
or are based on, internal data or publicly available data from various independent sources. Although the Issuer
believes that the external sources used are reliable, the Issuer has not independently verified the information
provided by such sources.
A43380138
10


Document Outline